Next Article in Journal
Anti-Tumor Effects of a Penetratin Peptide Targeting Transcription of E2F-1, 2 and 3a Is Enhanced When Used in Combination with Pemetrexed or Cisplatin
Previous Article in Journal
Correction: Pavlov, Y.I., et al. DNA Polymerases at the Eukaryotic Replication Fork Thirty Years After: Connection to Cancer. Cancers 2020, 12, 3489
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Cancers
Volume 13
Issue 5
10.3390/cancers13050971
cancers-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Addendum to Cancers 2020, 12(10), 2748.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Addendum

Addendum: Manabu, K., et al. Prognostic Significance of Aberrant Claudin-6 Expression in Endometrial Cancer. Cancers 2020, 12, 2748

by
Manabu Kojima
1,2,†,
Kotaro Sugimoto
1,*,†,
Mizuko Tanaka
1,
Yuta Endo
1,
Hitomi Kato
1,
Tsuyoshi Honda
3,
Shigenori Furukawa
2,
Hiroshi Nishiyama
3,
Takafumi Watanabe
2,
Shu Soeda
2,
Keiya Fujimori
2 and
Hideki Chiba
1,*
1
Department of Basic Pathology, Fukushima Medical University School of Medicine, Fukushima 960-1295, Japan
2
Department of Obstetrics and Gynecology, Fukushima Medical University School of Medicine, Fukushima 960-1295, Japan
3
Department of Obstetrics and Gynecology, Iwaki City Medical Center, Iwaki 973-8402, Japan
*
Authors to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Cancers 2021, 13(5), 971; https://doi.org/10.3390/cancers13050971
Submission received: 21 January 2021 / Accepted: 11 February 2021 / Published: 26 February 2021
Versions Notes
The authors wish to make the following correction to this paper [1].
The authors would like to acknowledge Yuko Hashimoto and Shigeyuki Asano for providing cancer tissues. Therefore, the following sentence should be added in the “Acknowledgments” section:
“We are also grateful to Yuko Hashimoto and Shigeyuki Asano for providing cancer tissues.”
The authors would like to apologize for this omission from the original manuscript. The change does not affect the scientific results.

Reference

  1. Kojima, M.; Sugimoto, K.; Tanaka, M.; Endo, Y.; Kato, H.; Honda, T.; Furukawa, S.; Nishiyama, H.; Watanabe, T.; Soeda, S.; et al. Prognostic Significance of Aberrant Claudin-6 Expression in Endometrial Cancer. Cancers 2020, 12, 2748. [Google Scholar] [CrossRef]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Kojima, M.; Sugimoto, K.; Tanaka, M.; Endo, Y.; Kato, H.; Honda, T.; Furukawa, S.; Nishiyama, H.; Watanabe, T.; Soeda, S.; et al. Addendum: Manabu, K., et al. Prognostic Significance of Aberrant Claudin-6 Expression in Endometrial Cancer. Cancers 2020, 12, 2748. Cancers 2021, 13, 971. https://doi.org/10.3390/cancers13050971

AMA Style

Kojima M, Sugimoto K, Tanaka M, Endo Y, Kato H, Honda T, Furukawa S, Nishiyama H, Watanabe T, Soeda S, et al. Addendum: Manabu, K., et al. Prognostic Significance of Aberrant Claudin-6 Expression in Endometrial Cancer. Cancers 2020, 12, 2748. Cancers. 2021; 13(5):971. https://doi.org/10.3390/cancers13050971

Chicago/Turabian Style

Kojima, Manabu, Kotaro Sugimoto, Mizuko Tanaka, Yuta Endo, Hitomi Kato, Tsuyoshi Honda, Shigenori Furukawa, Hiroshi Nishiyama, Takafumi Watanabe, Shu Soeda, and et al. 2021. "Addendum: Manabu, K., et al. Prognostic Significance of Aberrant Claudin-6 Expression in Endometrial Cancer. Cancers 2020, 12, 2748" Cancers 13, no. 5: 971. https://doi.org/10.3390/cancers13050971

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop